RELISA ANA SCREENING TEST SYSTEM, MODEL 7096-11

Antinuclear Antibody (enzyme-labeled), Antigen, Controls

IMMUNO CONCEPTS, INC.

The following data is part of a premarket notification filed by Immuno Concepts, Inc. with the FDA for Relisa Ana Screening Test System, Model 7096-11.

Pre-market Notification Details

Device IDK992041
510k NumberK992041
Device Name:RELISA ANA SCREENING TEST SYSTEM, MODEL 7096-11
ClassificationAntinuclear Antibody (enzyme-labeled), Antigen, Controls
Applicant IMMUNO CONCEPTS, INC. 2280 SPRINGLAKE RD. SUITE 106 Dallas,  TX  75234
ContactEric S Hoy
CorrespondentEric S Hoy
IMMUNO CONCEPTS, INC. 2280 SPRINGLAKE RD. SUITE 106 Dallas,  TX  75234
Product CodeLJM  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-06-17
Decision Date1999-07-23
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.